Theravance Biopharma Inc. (TBPH)
8.64
0.11 (1.29%)
At close: Jan 15, 2025, 3:59 PM
8.61
-0.35%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -11.26 | -8.9 | -3.85 | -3.98 | -6.09 | -6.41 | -5.12 | -7.48 | -3.07 | -2 | -4.66 | -76.11 | -6.7 |
| PS Ratio | 10.82 | 16.08 | 13.88 | 15.42 | 19.61 | 22.88 | 94.90 | 29.30 | 13.29 | 40.54 | 3.22K | 5.60 | 49.31 |
| PB Ratio | 2.92 | 1.87 | -2.27 | -3.65 | -6.43 | -26.77 | 12.68 | 4.07 | 2.30 | 1.63 | -42.78 | -104.26 | -5.2 |
| P/FCF Ratio | -21.08 | -4.4 | -3.63 | -4.31 | -5.96 | -11.5 | -7.18 | -14.1 | -3.26 | -2.66 | -5.89 | -5.99 | -8.41 |
| P/OCF Ratio | -23.02 | -4.42 | -3.69 | -4.42 | -6.04 | -12.24 | -7.26 | -14.4 | -3.31 | -2.7 | -6.02 | -6.12 | -8.78 |
| OCF/S Ratio | -0.47 | -3.64 | -3.76 | -3.48 | -3.24 | -1.87 | -13.07 | -2.03 | -4.01 | -14.99 | -535.22 | -0.92 | -5.62 |
| Debt / Equity Ratio | 0.23 | 0.17 | -1.93 | -2.13 | -2.2 | -8.81 | 1.94 | 0.64 | n/a | n/a | n/a | n/a | -0.00 |
| Quick Ratio | 5.39 | 12.26 | 4.09 | 3.02 | 3.03 | 5.41 | 5.79 | 10.48 | 4.60 | 7.62 | 0.10 | 0.15 | 0.06 |
| Current Ratio | 5.39 | 12.31 | 4.26 | 3.18 | 3.03 | 5.41 | 6.05 | 10.73 | 4.80 | 7.92 | 0.38 | 0.48 | 0.06 |
| Asset Turnover | 0.15 | 0.08 | 0.15 | 0.15 | 0.18 | 0.11 | 0.03 | 0.08 | 0.14 | 0.03 | 0.01 | 6.21 | 1.07 |
| Interest Coverage | -23.84 | -14.44 | -5.5 | -6.68 | -7.91 | -22.78 | -30.43 | -128.54 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.26 | -0.21 | 0.59 | 0.92 | 1.06 | 4.18 | -2.48 | -0.54 | -0.75 | -0.82 | 9.17 | 1.37 | 0.78 |
| Return on Assets (ROA) | -0.14 | -0.15 | -0.53 | -0.59 | -0.58 | -0.38 | -0.65 | -0.3 | -0.61 | -0.7 | -6.21 | -0.46 | -7.91 |
| Return on Capital (ROIC) | -0.16 | -0.16 | -0.82 | -0.86 | -0.85 | -0.52 | -0.69 | -0.31 | -0.73 | -0.78 | 13.39 | 5.60 | 4.96 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 29.26% | 87.17% | 86.83% | -263.16% | -198.65% | 98.82% | 60.81% | 94.05% | 88.95% | 65.28% | -53.25K% | 12.41% | 74.12% |
| Net Profit Margin | -96.11% | -180.78% | -360.55% | -386.9% | -322.08% | -357.01% | -1.85K% | -391.94% | -432.56% | -2.03K% | -69.15K% | -7.36% | -736.06% |
| Pretax Profit Margin | -85.8% | -180.76% | -360.83% | -398.76% | -329.2% | -374.5% | -1.77K% | -371.15% | -430.3% | -1.97K% | -69.15K% | -7.36% | -736.06% |
| Operating Profit Margin | -97.58% | -179.09% | -466.06% | -414.37% | -343.14% | -395.48% | -1.69K% | -370.96% | -431.8% | -1.99K% | -69.15K% | -7.36% | -736.06% |
| FCF Margin | -51.35% | -365.29% | -381.96% | -357.68% | -328.78% | -198.95% | -1.32K% | -207.87% | -407.12% | -1.53K% | -54.73K% | -93.51% | -586.07% |
| EBITDA Margin | -71.17% | -155.53% | -450.88% | -409.14% | -276.91% | -351.89% | -1.68K% | -361.86% | -424.37% | -1.95K% | -67.98K% | -4.86% | -710.19% |